Stay updated with breaking news from John Strickler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
John Strickler, MD, introduces a panel of medical experts who will provide key insights for considerations in the 3L colorectal cancer treatment setting.
Derrick Cameron had a vision of savoring the sun, riding his motorcycle, and spending more time with his family when he retired from the Georgia Depar
The FDA has approved Tukysa (tucatinib) plus trastuzumab for adults with previously treated, RAS wild-type, HER2+ colorectal cancer.
The combination of HER2-targeted agents is already approved for use in breast cancer and is now is the first treatment approved for HER2-positive colorectal cancer.
The FDA has approved Tukysa (tucatinib) plus trastuzumab for adults with previously treated RAS wild-type, HER2-positive metastatic colorectal cancer.